Robert W. Ross's Net Worth
$325 Thousand
Who is Robert W. Ross?
Robert W. Ross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Surface Oncology, Inc., and Xilio Therapeutics, Inc..
SEC CIK
Robert W. Ross's CIK is 0001733077
Past Insider Trading and Trends
2022 was Robert W. Ross's most active year for acquiring shares with 3 total transactions. Robert W. Ross's most active month to acquire stocks was the month of January. 2020 was Robert W. Ross's most active year for disposing of shares, totalling 4 transactions. Robert W. Ross's most active month to dispose stocks was the month of December. 2019 saw Robert W. Ross paying a total of $103,400.00 for 115,000 shares, this is the most they've acquired in one year. In 2021 Robert W. Ross cashed out on 43,500 shares for a total of $323,850.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Surface Oncology, Inc. No price found
Chief Executive OfficerRobert W. Ross used to own units in Common Stock but no longer holds any shares there. In the year 2018 Robert W. Ross acquired a total of 161,000 shares in Surface Oncology, Inc. at a cost of $103,400.00, Robert also disposed a total of 161,000 shares of Surface Oncology, Inc. equalling to $428,561.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -83.19K |
—
|
—
|
0
|
Sep 8
| |||
Form 4
| -16.73% | -16.71K |
$0.94 | -$15,710.22 | 83.19K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -9.59% | -10.59K |
$1.72 | -$18,221.68 | 99.91K |
Aug 3
| |||
Form 4
| +102.75% | 56K |
—
|
—
| 110.5K |
Mar 1
| |||
Form 4
| -38.07% | -33.50K |
$6.10 | -$204,350.00 | 54.5K |
Jul 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| -1.12% | -1.00K |
$11.35 | -$11,350.00 | 88K |
Scheduled
|
Feb 16
| ||
Form 4
| -9.18% | -9.00K |
$12.02 | -$108,150.00 | 89K |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
| -1.01% | -1.00K |
$10.48 | -$10,480.00 | 98K |
Scheduled
|
Dec 15
| ||
Form 4
| -1.40% | -1.41K |
$10.05 | -$14,120.25 | 99K |
Scheduled
|
Dec 11
| ||
Form 4
| -0.59% | -595.00 |
$10.05 | -$5,979.75 | 100.41K |
Scheduled
|
Nov 11
| ||
Form 4
| -3.81% | -4.00K |
$10.05 | -$40,200.00 | 101K |
Scheduled
|
Oct 14
| ||
Form 4
| +320.00% | 80K |
—
|
—
| 105K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 25K |
$4.14 | $103,400.00 | 25K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||